ICICI Bank has announced its earnings call schedule for the third quarter of fiscal year 2026, informing stakeholders through a regulatory filing dated January 13, 2026. The bank will conduct comprehensive discussions on its financial performance for the quarter and nine months ended December 31, 2025.

Earnings Call Schedule

The bank has organized two separate conference calls on January 17, 2026, to accommodate different stakeholder groups. The structured approach ensures comprehensive coverage of the financial results across media and investment communities.

Dial-in Information

ICICI Bank has provided comprehensive dial-in details to facilitate participation from multiple geographical locations. The bank offers both universal and toll-free numbers to ensure accessibility for participants worldwide.

Registration and Access

Participants can pre-register for the earnings call through the designated portal provided by the bank. The pre-registration system helps streamline the call process and ensures smooth participation for all attendees.

The bank has also confirmed that audio recordings and transcripts of both calls will be made available on its official website at www.icici.bank.in , ensuring transparency and accessibility for stakeholders who cannot participate in the live sessions.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 requirements, with the filing signed by Vivek Ranjan from the Associate Leadership Team. The bank has also notified international exchanges including the New York Stock Exchange, Japan Securities Dealers Association, Singapore Stock Exchange, and SIX Swiss Exchange Ltd., reflecting its global presence and compliance obligations.

ICICI Bank has announced the allotment of equity shares under its Employee Stock Option Scheme, marking another milestone in the bank's employee compensation structure. The allotment was completed on January 13, 2026, following the established corporate governance procedures.

Share Allotment Details

The bank has allotted a total of 1,185,510 equity shares under the ICICI Bank Employees Stock Option Scheme-2000. The key parameters of this allotment are presented below:

Approval Process and Authorization

The share allotment received approval from two Executive Directors of ICICI Bank on January 13, 2026, with the final approval granted at 10:45 a.m. This approval was executed under the authority delegated by the Board of Directors during their meeting held on October 21, 2023.

The approval process demonstrates the bank's adherence to established corporate governance protocols, ensuring proper authorization levels for equity-related decisions. The delegation of powers from the Board to Executive Directors enables efficient execution of routine ESOP allotments while maintaining oversight and control.

Employee Stock Option Scheme Framework

The allotment falls under the ICICI Bank Employees Stock Option Scheme-2000, which serves as a key component of the bank's employee compensation and retention strategy. This scheme allows eligible employees to acquire equity shares in the bank, aligning their interests with shareholder value creation.

The ESOP mechanism provides employees with the opportunity to participate in the bank's growth story while serving as an effective tool for talent retention and motivation. Such schemes are particularly significant in the banking sector, where human capital plays a crucial role in business success.

Regulatory Compliance and Communication

ICICI Bank has fulfilled its regulatory obligations by formally notifying both major stock exchanges about the share allotment. The bank communicated the details to BSE Limited at Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai, and the National Stock Exchange of India Limited at Exchange Plaza, Bandra-Kurla Complex, Mumbai.

This communication ensures transparency and keeps all stakeholders informed about changes in the bank's share capital structure. The formal notification process aligns with listing requirements and maintains the bank's commitment to regulatory compliance and corporate transparency.